◆英語タイトル：Vascular Biogenics Ltd (VBLT) - Financial and Strategic SWOT Analysis Review
Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for cancer therapy. The company also administers treatment for solid tumor indications, with clinical trials in rGBM, thyroid cancer and ovarian cancer. VBL designs its product to address oncology indications in solid tumors, by the blood vessels required for tumor growth. It also developed programs based proprietary platform technologies including an oncology program and an anti-inflammatory program. VBL is headquartered in Or Yehuda, Israel.
Vascular Biogenics Ltd Key Recent Developments
Nov 20,2018: VBL Therapeutics announces third quarter 2018 financial results
Oct 23,2018: Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics” Lead Drug Candidate VB-111 until October 2033
Aug 16,2018: VBL Therapeutics announces second quarter 2018 financial results
Jun 05,2018: VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018
May 17,2018: VBL Therapeutics Announces First Quarter 2018 Financial Results
This comprehensive SWOT profile of Vascular Biogenics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vascular Biogenics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Vascular Biogenics Ltd – Key Information
Vascular Biogenics Ltd – Overview
Vascular Biogenics Ltd – Key Employees
Vascular Biogenics Ltd – Key Employee Biographies
Vascular Biogenics Ltd – Key Operational Heads
Vascular Biogenics Ltd – Major Products and Services
Vascular Biogenics Ltd – History
Vascular Biogenics Ltd – Company Statement
Vascular Biogenics Ltd – Locations And Subsidiaries
Vascular Biogenics Ltd – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Vascular Biogenics Ltd – Business Description
Vascular Biogenics Ltd – Corporate Strategy
Vascular Biogenics Ltd – SWOT Analysis
SWOT Analysis – Overview
Vascular Biogenics Ltd – Strengths
Vascular Biogenics Ltd – Weaknesses
Vascular Biogenics Ltd – Opportunities
Vascular Biogenics Ltd – Threats
Vascular Biogenics Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Vascular Biogenics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Vascular Biogenics Ltd, Key Information
Vascular Biogenics Ltd, Key Ratios
Vascular Biogenics Ltd, Share Data
Vascular Biogenics Ltd, Major Products and Services
Vascular Biogenics Ltd, History
Vascular Biogenics Ltd, Key Employees
Vascular Biogenics Ltd, Key Employee Biographies
Vascular Biogenics Ltd, Key Operational Heads
Vascular Biogenics Ltd, Other Locations
Vascular Biogenics Ltd, Subsidiaries
Vascular Biogenics Ltd, Key Manufacturing facilities
Vascular Biogenics Ltd, Key Competitors
Vascular Biogenics Ltd, SWOT Analysis
Vascular Biogenics Ltd, Ratios based on current share price
Vascular Biogenics Ltd, Annual Ratios
Vascular Biogenics Ltd, Interim Ratios
Capital Market Ratios
List of Figures
Vascular Biogenics Ltd, Performance Chart
Vascular Biogenics Ltd, Ratio Charts
| ★海外企業調査レポート[Vascular Biogenics Ltd (VBLT)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら